Education Hub
Your central resource for evidence-based content in metabolic, cardiovascular, and renal medicine.
Diabetes
Contemporary approaches to diabetes management, complications, and therapeutic advances.
2022: Every Diabetes Guideline Update... in 30 minutes!
35:18
@GoggleDocs give their overview of the last year in Diabetes Guideline updates; NICE, ADA/EASD and KDIGO.
Diabetes Under 40: Youth-Onset Diabetes Explained
3:54
In this @goggledocs video, Dr Amar Puttanna (Consultant Diabetologist) explains the increasingly common diagnosis of 'Youth-Onset Diabetes
Disrupting Type 2 Diabetes: Mounjaro's UK Launch
14:33
Patrick and Amrit discuss the launch of Mounjaro, the latest blockbuster medication in the management of type 2 diabetes.
Glucose Monitoring in Type 1 Diabetes... the NICE guidance
11:03
In this @GoggleDocs video Dr Patrick and Dr Amar summarise the NICE Guidance on Glucose Monitoring in Type 1 Diabetes.
ADA 2025: The Big 4 (Plus One) – Key Trials That Could Reshape Diabetes
8:51
Five high-impact trials from #ADA2025 – broken down fast by Drs Amrit Lamba, Amar Puttanna, and Patrick Holmes.
The GLP-1 Story... (a GoggleDocs Podcast)
58:36
In this GoggleDocs podcast we discuss the journey of GLP-1 agonists, from Gila Monster Saliva to Ozempic, Wegovy and Mounjaro.
GoggleDocs Pod # 4 | Underserved Communities in Diabetes
45:52
The united colours of Diabetes"... each person living with diabetes has their own unique physical, psychological and social characteristics.
Mounjaro for Better Sleep?
14:33
In this video the @GoggleDocs preview the upcoming American Diabetes Association annual conference, taking place in June 2024, in Orlando, Florida.
CGM for Type 2 Diabetes... the NICE guidance
11:25
In this GoggleDocs video Dr Amar and Dr Amrit discuss how Continuous Glucose Monitoring (CGM) could revolutionise the insulin management in Type 2 Diabetes.
Diabetes and Obesity - ADA 2023 Preview
14:15
In this video @GoggleDocs will preview the annual American Diabetes Association's Scientific Sessions conference which takes place in San Diego.
WEIGHT LOSS... and the diabetes crisis
13:03
We review the latest issues for Ozempic, Trulicity and Tresiba for patients with Diabetes.
Type 1 Diabetes: The Power of Early Detection
12:20
This video (including its concept, creation and content) has solely been developed and produced by Dr Patrick Holmes and Dr Amrit Lamba.
ACHIEVE-1: Oral GLP-1 in T2D – ADA 2025 Preview
1:56
Dr Patrick Holmes walks through ACHIEVE-1, a key ADA 2025 trial on orforglipron – the first oral non-peptide GLP-1RA for type 2 diabetes.
Obesity
Weight management, metabolic health, and the evolving treatment landscape for obesity.
Breaking News in Obesity: STEP1 (w Dr Sarah Davies)
18:42
Patrick and Amrit are joined by fellow Primary Care GP, Dr Sarah Davies, to discuss the recently published STEP 1 trial.
The Human Costs of Obesity
10:30
In this @GoggleDocs podcast we discuss the far-reaching consequences of overweight and obesity, including the role of social deprivation and health inequalities.
Wegovy, Ozempic, Rybelsus: a 2-minute summary
2:07
Dr Patrick Holmes brings us up to speed with the molecule that has taken the world of diabetes and bariatric medicine by storm
Breaking News top-line results of the TRIUMPH-4 study (retatrutide)
2:20
Retatrutide delivers AGAIN!!! Experimental weight-loss treatment retatrutide tested in a phase 3 randomised control trial in Overweight/Obese adults with osteoarthritic knee pain.
Ozempic... The Good, the Bad and the Ugly
5:13
Dr Patrick Holmes from @GoggleDocs brings you a 2024 update on Semaglutide (aka Ozempic, Wegovy, Rybelsus)... from the latest scientific evidence to the growing pains.
Weight loss management... NEW OPTIONS
14:29
In this video our GoggleDocs team look at the recently announced NICE technical appraisal document for the use of Semaglutide in Overweight and Obesity.
CagriSema: REDEFINE 1 & 2 Results – ADA 2025 – will two be better than one?
1:24
Two phase 3 trials, two populations, one dual-incretin therapy. Dr Patrick Holmes breaks down REDEFINE 1.
Can #orforglipron an oral #glp1 maintain #weightloss ?: The ATTAIN MAINT...
2:18
This is a video about ATTAIN MAINTAIN Trial-2 1 00:00 ATTAIN MAINTAIN Trial-2 1
Obesity and Cardiovascular Disease
33:16
In this @GoggleDocs podcast, we take a deep dive on Obesity and Overweight - looking at international trends, the risk of cardiovascular disease and the different treatment modalities.
MOUNJARO: Mastering Weight Loss Maintenance | SURMOUNT-4 at EASD
5:42
Join @goggledocs, as we discuss the latest science investigating the durability of weight loss when using Mounjaro.
Muscle Matters: BELIEVE & COURAGE at ADA 2025
2:08
Dr Amar Puttanna covers two important ADA 2025 trials that zoom in on muscle preservation during GLP-1-driven weight loss.
Related Cardio-Renal-Metabolic Conditions
Heart failure, chronic kidney disease, atherosclerotic cardiovascular disease, lipid disorders, and other conditions in metabolic medicine.
Breaking News: SGLT2i in ACUTE Heart Failure
18:42
This bite-sized video is a summary of the recent EMPULSE study, that investigated the use of Empagliflozin in people admitted to hospital with acute heart failure.
Breakthroughs in Kidney Disease & Heart Failure
18:42
@GoggleDocs summarises evidence from the EMPA-KIDNEY and DELIVER studies, and how they impact clinical practice and people living with CKD.
The Chronic Kidney Disease Playbook 2024
18:42
Chronic Kidney Disease affects up to 1 billion people worldwide. With complications including reduced life expectancy, cardiovascular disease and kidney failure.
ESC 2022 - latest cardiology research reviewed
18:42
The GoggleDocs team review the recent European Society of Cardiology (ESC) Congress 2022, Barcelona, and highlight their key sessions.
Cafés, canals and cardiology. ESC 2023 Preview
18:42
We preview the European Society of Cardiology's Annual Congress, in Amsterdam (25-28 August 2023). Focusing on the latest with Semaglutide in Heart Failure.
The Heart Failure breakthrough of 2024?
18:42
@GoggleDocs summarise the breaking news in Heart Failure management with Finerenone's (Kerendia) latest scientific data.
Finerenone... adding life to years in Kidney Disease
18:42
@GoggleDocs give a summary of the latest NICE recommendations for Finerenone and the practical aspects of its use.
Weight, Risk & Heart Health | Insights from ESC 2023
18:42
We pick our top three Heart health announcements from the ESC Annual Congress in Amsterdam (August 2023); covering the latest on Semaglutide in heart failure.
Semaglutide Saving Lives in Kidney Disease
18:42
In this video @GoggleDocs review the latest evidence for using Semaglutide in the management of people with Chronic Kidney Disease and Type 2 Diabetes.